T. Rowe Price Associates’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43K Buy
58,482
+10,329
+21% +$7.6K ﹤0.01% 3015
2025
Q1
$39K Buy
48,153
+7,984
+20% +$6.47K ﹤0.01% 2955
2024
Q4
$56K Hold
40,169
﹤0.01% 2912
2024
Q3
$42K Buy
40,169
+2,421
+6% +$2.53K ﹤0.01% 2949
2024
Q2
$66K Buy
37,748
+6,897
+22% +$12.1K ﹤0.01% 2819
2024
Q1
$74K Buy
30,851
+7,608
+33% +$18.2K ﹤0.01% 2825
2023
Q4
$78K Buy
23,243
+1,116
+5% +$3.75K ﹤0.01% 2743
2023
Q3
$83K Sell
22,127
-16,659
-43% -$62.5K ﹤0.01% 2690
2023
Q2
$166K Buy
38,786
+1,444
+4% +$6.18K ﹤0.01% 2579
2023
Q1
$256K Sell
37,342
-3,379
-8% -$23.2K ﹤0.01% 2420
2022
Q4
$323K Sell
40,721
-15,055
-27% -$119K ﹤0.01% 2342
2022
Q3
$537K Buy
55,776
+4,447
+9% +$42.8K ﹤0.01% 2079
2022
Q2
$372K Buy
51,329
+12,995
+34% +$94.2K ﹤0.01% 2338
2022
Q1
$495K Buy
38,334
+1,400
+4% +$18.1K ﹤0.01% 2336
2021
Q4
$589K Sell
36,934
-1,144
-3% -$18.2K ﹤0.01% 2310
2021
Q3
$612K Buy
38,078
+268
+0.7% +$4.31K ﹤0.01% 2276
2021
Q2
$523K Buy
37,810
+1,284
+4% +$17.8K ﹤0.01% 2370
2021
Q1
$534K Sell
36,526
-50,419
-58% -$737K ﹤0.01% 2332
2020
Q4
$1.51M Sell
86,945
-210
-0.2% -$3.65K ﹤0.01% 1735
2020
Q3
$1.6M Buy
87,155
+35,875
+70% +$658K ﹤0.01% 1621
2020
Q2
$916K Sell
51,280
-13,874
-21% -$248K ﹤0.01% 1824
2020
Q1
$1.06M Sell
65,154
-3,589
-5% -$58.2K ﹤0.01% 1677
2019
Q4
$1.24M Buy
68,743
+2,493
+4% +$44.9K ﹤0.01% 1802
2019
Q3
$1.34M Sell
66,250
-1,865
-3% -$37.8K ﹤0.01% 1687
2019
Q2
$1.51M Sell
68,115
-426,104
-86% -$9.41M ﹤0.01% 1678
2019
Q1
$6.74M Sell
494,219
-329,442
-40% -$4.49M ﹤0.01% 1366
2018
Q4
$7.45M Sell
823,661
-449,658
-35% -$4.07M ﹤0.01% 1351
2018
Q3
$21M Sell
1,273,319
-441,637
-26% -$7.29M ﹤0.01% 1218
2018
Q2
$24M Buy
1,714,956
+222,857
+15% +$3.12M ﹤0.01% 1148
2018
Q1
$16.5M Buy
1,492,099
+572,897
+62% +$6.33M ﹤0.01% 1242
2017
Q4
$8.09M Sell
919,202
-292,270
-24% -$2.57M ﹤0.01% 1357
2017
Q3
$16.2M Buy
1,211,472
+528,020
+77% +$7.05M ﹤0.01% 1235
2017
Q2
$9.81M Sell
683,452
-122,894
-15% -$1.76M ﹤0.01% 1325
2017
Q1
$17.1M Sell
806,346
-38,486
-5% -$814K ﹤0.01% 1222
2016
Q4
$23.8M Buy
844,832
+13,510
+2% +$380K ﹤0.01% 1080
2016
Q3
$22.3M Buy
+831,322
New +$22.3M ﹤0.01% 1095